MHC Intratumoral Heterogeneity May Predict Cancer Progression and Response to Immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MHC Intratumoral Heterogeneity May Predict Cancer Progression and Response to Immunotherapy

Published:2018-01-29 Issue: Volume:9 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Romero Irene,Garrido Cristina,Algarra Ignacio,Chamorro Virginia,Collado Antonia,Garrido Federico,Garcia-Lora Angel M.

Funder

Instituto de Salud Carlos III

Consejería de Economía, Innovación, Ciencia y Empleo, Junta de Andalucía

European Commission

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference49 articles.

1. Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing;Zhang;Science,2014

2. Combination therapy targeting BCL6 and phospho-STAT3 defeats intratumor heterogeneity in a subset of non-small cell lung cancers;Deb;Cancer Res,2017

3. Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients;Siravegna;Nat Med,2015

4. Clonal heterogeneity and tumor evolution: past, present, and the future;McGranahan;Cell,2017

5. Cancer genome landscapes;Vogelstein;Science,2013

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selective activation of IFNγ–ipilimumab enhances the therapeutic effect and safety of ipilimumab;International Journal of Biological Macromolecules;2024-04

2. Expanded Alternatives of CRISPR–Cas9 Applications in Immunotherapy of Colorectal Cancer;Molecular Diagnosis & Therapy;2023-10-31

3. A Potential Antibody–Drug Conjugate Targeting Human LIV1 for the Treatment of Triple-Negative Breast Cancer;Pharmaceutical Fronts;2023-08-24

4. Primary and acquired resistance to first-line therapy for clear cell renal cell carcinoma;Cancer Drug Resistance;2023-08-02

5. Recruiting T cells and sensitizing tumors to NKG2D immune surveillance for robust antitumor immune response;Journal of Controlled Release;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3